Access cutting-edge spinal muscular atrophy treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.
Access spinal muscular atrophy specialists in Palo Alto at no cost
This study follows strict safety protocols and ethical guidelines
All study-related spinal muscular atrophy treatment provided free
This double-blind, Phase 2, multiple-dose study will be conducted to evaluate the PK/PD, efficacy, safety, and tolerability of apitegromab in subjects \<2 years old with 5q autosomal recessive SMA who have delayed motor milestones for their age attributed to SMA at the discretion of the Investigator or a Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP-INTEND) score \<55.
Sponsor: Scholar Rock, Inc.
Check if you qualify for this spinal muscular atrophy clinical trial in Palo Alto, CA
If you're searching for spinal muscular atrophy treatment options in Palo Alto, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced spinal muscular atrophy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.